.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Farmers Insurance
US Department of Justice
Johnson and Johnson
Deloitte
Colorcon
Daiichi Sankyo
Medtronic
Baxter
Argus Health

Generated: September 22, 2017

DrugPatentWatch Database Preview

STATOBEX Drug Profile

« Back to Dashboard

Which patents cover Statobex, and when can generic versions of Statobex launch?

Statobex is a drug marketed by Teva and is included in three NDAs.

The generic ingredient in STATOBEX is phendimetrazine tartrate. There are five drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

Summary for Tradename: STATOBEX

Patents:0
Applicants:1
NDAs:3
Bulk Api Vendors: see list8
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:STATOBEX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
STATOBEX
phendimetrazine tartrate
CAPSULE;ORAL085507-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
STATOBEX
phendimetrazine tartrate
TABLET;ORAL086013-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
STATOBEX-G
phendimetrazine tartrate
TABLET;ORAL085095-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Argus Health
Boehringer Ingelheim
Baxter
Novartis
Dow
Merck
Fuji
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot